IQVIA Holdings Investor Presentation — July 2019

Document content

Copyright © 2019 IQVIA. All rights reserved.

July 24, 2019Q2 2019 Earnings Call1

This presentation should be viewed in conjunction with IQVIA’s Q2 2019 earnings callLegal

Safe Harbor Statement forForward -Looking Statements

This presentation contains “forward -lookingstatements” within themeaning ofthefederal securities laws, including Section 27AoftheSecurities Actof1933 ,asamended, andSection 21EoftheSecurities Exchange Actof1934 ,as

amended, including, without limitation, ourfull-year andthird quarter 2019 guidance .Inthiscontext, forward -looking statements often address expected future business andfinancial performance andfinancial condition, andoften

contain words such as“expect,” “anticipate,” “intend,” “plan,”“believe,” “seek,”“see,”“will,”“would,” “target,” similar expressions, andvariations ornegatives ofthese words .Actual results may differ materially from ourexpectations dueto

anumber offactors, including, butnotlimited to,thefollowing :thatmost ofourcontracts may beterminated onshort notice, andwemay lose orexperience delays with large client contracts orbeunable toenter intonew contracts ;

imposition ofrestrictions onouruseofdata bydata suppliers ortheir refusal tolicense data tous;anyfailure byustocomply withcontractual, regulatory orethical requirements under ourcontracts, including current orchanges todata

protection andprivacy laws;breaches ormisuse ofourorouroutsourcing partners’ security orcommunications systems ;hardware andsoftware failures, delays intheoperation ofourcomputer andcommunications systems orthe

failure toimplement system enhancements ;failure tomeet ourproductivity orbusiness transformation objectives ;failure tosuccessfully invest ingrowth opportunities ;ourability toprotect ourintellectual property rights and our

susceptibility toclaims byothers thatweareinfringing ontheir intellectual property rights ;theexpiration orinability toacquire third party licenses fortechnology orintellectual property ;anyfailure byustoaccurately andtimely price and

formulate cost estimates forcontracts, ortodocument change orders ;therate atwhich ourbacklog converts torevenue ;ourability toacquire, develop and implement technology necessary forourbusiness ;consolidation inthe

industries inwhich ourclients operate ;risks related toclient ortherapeutic concentration ;therisks associated with operating onaglobal basis, including currency orexchange rate fluctuations andlegal compliance, including anti-

corruption laws;risks related tochanges inaccounting standards, including theimpact ofthechanges totherevenue recognition standards ;general economic conditions inthemarkets inwhich weoperate, including financial market

conditions andrisks related tosales togovernment entities ;theimpact ofchanges intaxlaws andregulations ;and ourability tosuccessfully integrate, and achieve expected benefits from, ouracquired businesses .Forafurther